World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
109
Citations
58378
World Ranking
5681
National Ranking
3059

Overview

Michael J. Borowitz is affiliated with Johns Hopkins University in the United States. Their research primarily focuses on the field of Medicine, with notable subfields including Public Health, Environmental and Occupational Health; Hematology; Pediatrics, Perinatology and Child Health; Pathology and Forensic Medicine; and Genetics.

The scientist has contributed extensively to topics surrounding Acute Lymphoblastic Leukemia research, Childhood Cancer Survivors' Quality of Life, Acute Myeloid Leukemia Research, Chronic Myeloid Leukemia Treatments, Lymphoma Diagnosis and Treatment, CAR-T cell therapy research, and Chronic Lymphocytic Leukemia Research.

Frequent co-authors in their collaborative work include Mignon L. Loh, Stephen P. Hunger, Meenakshi Devidas, Elizabeth A. Raetz, and Brent L. Wood.

Michael J. Borowitz has published widely in several venues, with the most frequent being Blood, Journal of Clinical Oncology, Leukemia, Blood Advances, and The Lancet Haematology.

Some recent papers authored or co-authored by Michael J. Borowitz include:

  • International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data (2022, Blood)
  • The genomic landscape of pediatric acute lymphoblastic leukemia (2022, Nature Genetics)
  • Effect of Postreinduction Therapy Consolidation With Blinatumomab vs Chemotherapy on Disease-Free Survival in Children, Adolescents, and Young Adults With First Relapse of B-Cell Acute Lymphoblastic Leukemia (2021, JAMA)
  • Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia (2022, Blood)
  • International Consensus Classification of acute lymphoblastic leukemia/lymphoma (2022, Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin)

Best Publications

  • The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia

    Daniel A. Arber;Attilio Orazi;Robert Hasserjian;Jürgen Thiele

  • The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

    James W. Vardiman;Jüergen Thiele;Daniel A. Arber;Richard D. Brunning

  • Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia.

    Charles G Mullighan;Xiaoping Su;Jinghui Zhang;Ina Radtke

  • Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study.

    Michael J. Borowitz;Meenakshi Devidas;Stephen P. Hunger;W. Paul Bowman;W. Paul Bowman

  • Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Hematopoietic Reconstitution after High-Dose Chemotherapy and Autologous Bone Marrow Transplantation

    Stephen J. Brandt;William P. Peters;Susan K. Atwater;Joanne Kurtzberg

  • Improved Early Event-Free Survival With Imatinib in Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: A Children's Oncology Group Study

    Kirk R. Schultz;W. Paul Bowman;Alexander Aledo;William B. Slayton

  • The genomic landscape of hypodiploid acute lymphoblastic leukemia

    Linda Holmfeldt;Lei Wei;Ernesto Diaz-Flores;Michael Walsh

  • Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG)

    Kirk R. Schultz;D. Jeanette Pullen;Harland N. Sather;Jonathan J. Shuster

  • Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome.

    Richard C. Harvey;Richard C. Harvey;Charles G. Mullighan;Xuefei Wang;Kevin K. Dobbin

  • Guidelines for the diagnosis and monitoring of paroxysmal nocturnal hemoglobinuria and related disorders by flow cytometry.

    Michael J. Borowitz;Fiona E. Craig;Joseph A. DiGiuseppe;Andrea J. Illingworth

  • Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: Children's Oncology Group study AALL0031.

    K. R. Schultz;A. Carroll;N. A. Heerema;W. P. Bowman

  • PAX5 -driven subtypes of B-progenitor acute lymphoblastic leukemia

    Zhaohui Gu;Michelle L. Churchman;Kathryn G. Roberts;Ian Moore

  • Expression of the hematopoietic growth factor receptor FLT3 (STK-1/Flk2) in human leukemias.

    Catherine E. Carow;Mark Levenstein;Scott H. Kaufmann;Joseph Chen

  • Immunophenotyping of acute leukemia by flow cytometric analysis. Use of CD45 and right-angle light scatter to gate on leukemic blasts in three-color analysis.

    M J Borowitz;K L Guenther;K E Shults;G T Stelzer

  • Childhood Ki-1 lymphoma presenting with skin lesions and peripheral lymphadenopathy

    ME Kadin;D Sako;N Berliner;W Franklin

  • Dexamethasone and High-Dose Methotrexate Improve Outcome for Children and Young Adults With High-Risk B-Acute Lymphoblastic Leukemia: A Report From Children’s Oncology Group Study AALL0232

    Eric C. Larsen;Meenakshi Devidas;Si Chen;Wanda L. Salzer

  • Prognostic significance of minimal residual disease in high risk B-ALL: a report from Children’s Oncology Group study AALL0232

    Michael J. Borowitz;Brent L. Wood;Meenakshi Devidas;Mignon L. Loh

  • Clinical characteristics and treatment outcome of childhood acute lymphoblastic leukemia with the t(4;11)(q21;q23): a collaborative study of 40 cases.

    Ching Hon Pui;Lawrence S. Frankel;Andrew J. Carroll;Susana C. Raimondi

  • Inherited GATA3 variants are associated with Ph-like childhood acute lymphoblastic leukemia and risk of relapse

    Virginia Perez-Andreu;Kathryn G. Roberts;Richard C. Harvey;Wenjian Yang

  • Antigens of Human Pancreatic Adenocarcinoma Cells Defined by Murine Monoclonal Antibodies

    Richard S. Metzgar;Melissa T. Gaillard;Steven J. Levine;Francis L. Tuck

Frequent Co-Authors

Stephen P. Hunger
Stephen P. Hunger University of Pennsylvania
Meenakshi Devidas
Meenakshi Devidas St. Jude Children's Research Hospital
William L. Carroll
William L. Carroll New York University
Naomi J. Winick
Naomi J. Winick The University of Texas Southwestern Medical Center
Elizabeth A. Raetz
Elizabeth A. Raetz New York University
Mignon L. Loh
Mignon L. Loh University of California, San Francisco
Brent L. Wood
Brent L. Wood University of Washington
Andrew J. Carroll
Andrew J. Carroll University of Alabama at Birmingham
Nyla A. Heerema
Nyla A. Heerema The Ohio State University
Julie M. Gastier-Foster
Julie M. Gastier-Foster Baylor College of Medicine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in studying Medicine in the USA, there are also several related healthcare pathways you can consider. Many reputable schools now offer flexible degree options online, allowing you to start your healthcare career without relocating or disrupting your current commitments.

For those drawn to data and technology, an online bachelor's in health information management can be a smart entry point to the field. Another in-demand option is medical coding, and you may be wondering how much does it cost to become a medical coder. Affordable programs are available, letting you gain the necessary skills without taking on loads of debt.

Nursing remains a top healthcare career with steady job growth. Today, there are many affordable nursing programs online, ideal for busy students or working professionals. If you’re looking to advance your practice, research affordable online fnp programs to become a Family Nurse Practitioner.

These online degrees and certificate programs offer alternative pathways into healthcare, making it easier than ever to join this vital industry.

Best Scientists Citing Michael J. Borowitz

Trending Scientists